概括
在异质造血细胞移植后给予的非选择性β阻塞剂可能会延迟血小板移植并减少患者的存活率. 这一发现影响了移植后的护理和移植受体的药物选择.
科学领域:
- 血液学 血液学 血液学
- 移植医学 移植医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 全基性造血细胞移植 (HCT) 是血液恶性瘤的关键治疗方法.
- 血小板移植是HCT成功恢复的关键指标.
- 非选择性β抑制剂通常用于心血管疾病.
研究的目的:
- 调查非选择性β阻塞剂在HCT后对血小板移植的影响.
- 评估非选择性β阻塞剂对HCT患者生存结果的影响.
主要方法:
- 对接受异构HCT的患者的回顾性分析.
- 在接受非选择性β抑制剂和未接受非选择性β抑制剂的患者之间,血小板移植时间表的比较.
- 生存分析将β阻断剂的使用与患者的治疗结果关联起来.
主要成果:
- 接受非选择性β抑制剂的患者显示血小板移植显著延迟.
- 非选择性β-阻断剂的使用与HCT后的总生存率降低有关.
- 在其他植入参数中没有发现显著差异.
结论:
- 非选择性β-阻断剂可能会对异构HCT后的血小板恢复产生不利影响.
- 这些发现表明需要重新考虑在移植后的立即期内使用非选择性β-阻断剂.
- 需要进一步的前性研究来证实这些观察,并探索替代治疗策略.
相关概念视频
Bone Marrow Sampling and Transplants
266
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
266
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Intracellular Signaling Affects Focal Adhesions
2.5K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.5K
Role of Hematopoietic Growth Factors
1.2K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.2K
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K


